Hemostasiology. Antifibrinolytic mechanisms of the liver
Jedrychowski, A.; Parbhoo, S.P.; Hillenbrand, P.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 1139-1142
1977
ISSN/ISBN: 0070-4067 PMID: 417485 Document Number: 115902
Document emailed within 1 workday
Related Documents
Bliuger, A.F.; Maksimova, L.A.; Kartashova, O.I.; Briedis, L.P. 1976: Outcome of chronic cholestatic lesions of the liver (mechanisms of development of biliary liver cirrhosis) Terapevticheskii Arkhiv 48(9): 20-24Loginov, A.S.; Matiushin, B.N. 1996: Cytotoxic action of active forms of oxygen and mechanisms of development of a chronic process in the liver in liver disease Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 3-5
Kjellman, H.; Schannong, M. 1970: Tranexamic acid, a new antifibrinolytic agent Nordisk Medicin 83(6): 166-168
Sunde, N.A.; Bjerre, P.K. 2010: Antifibrinolytic treatment in subarachnoid hemorrhage Ugeskrift for Laeger 172(19): 1431
Manrique, R. 1984: Protease inhibitors and antifibrinolytic therapy Arquivos Brasileiros de Cardiologia 43(5): 355-360
Storm, O. 1975: Tranexamic acid (Cyclocapron, Kabi). An antifibrinolytic Ugeskrift for Laeger 137(20): 1120-1121
Schisano, G. 1978: The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage Surgical Neurology 10(4): 217-222
Walsh, M. 2017: Antifibrinolytic agents in acquired bleeding disorders Clinical Advances in Hematology and Oncology: H&o 15(5): 357-361
Loginov, A.S.; Damianov, B.D. 1972: Mechanisms by which liver diseases become chronic Sovetskaia Meditsina 35(2): 89-93
Morse, E.E. 1990: Mechanisms of hemolysis in liver disease Annals of Clinical and Laboratory Science 20(3): 169-174
Slunský, R. 1970: Personal experiences with the antifibrinolytic PAMBA in obstetrics and gynecology Zentralblatt für Gynakologie 92(12): 364-367
Davidoff, S.M. 1970: Experience with the antifibrinolytic agent Pamba in maxillofacial surgery Deutsche Stomatologie 20(5): 391-393
Lemgruber, I.; Maywald, V. 1970: Use of Transamine, new antifibrinolytic agent. Its use in gynecology, obstetrics and surgery Hospital (Rio de Janeiro) 77(1): 107-118
Dupin, J.P.; Boisseau, M.; Brasington, R.D.; Mesnard, P. 1978: Investigation and determination of the antifibrinolytic properties of dipeptides and synthetic compounds Pathologie-Biologie 26(5): 233-239
Anglés-Cano, E. 2000: High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms Circulation 102(25): E184-E185
Mogilevich, S.E.; Velikiĭ, N.N.; Khalmurodov, A.G. 1981: Possible mechanisms of the inhibiting effect of nicotinamide on lipogenesis in rat liver Biokhimiia 46(1): 103-109
Van Thiel, D.H.; Gavaler, J.S.; Eagon, P.K.; Lester, R. 1979: Mechanisms of hypogonadism and feminization in alcholic liver disease Zeitschrift für Gastroenterologie 17(7): 413-421
Gnoni, G.V.; Sciscioli, V.; Landriscina, C. 1977: Possible inhibitory mechanisms of acetyl CoA carboxylase from rat liver due to cyclic AMP Bollettino della Societa Italiana di Biologia Sperimentale 53(17): 1418-1424
Solopaev, B.P.; Kovalenko, I.A.; Sadovnikova, V.V.; Ermakova, G.A.; Gorbatsevich, G.S. 1973: Mechanisms of reparative regeneration of pathologically changed liver Biulleten' Eksperimental'noi Biologii i Meditsiny 76(11): 50-53
Marsland, T.; Griffin, T.; Ansell, J.; Hunter, R. 1981: Control of intraperitoneal haemorrhage with antifibrinolytic therapy in a patient with ovarian carcinoma Thrombosis and Haemostasis 46(2): 566